CN103110925A - Medicament for treating fracture - Google Patents

Medicament for treating fracture Download PDF

Info

Publication number
CN103110925A
CN103110925A CN 201310080307 CN201310080307A CN103110925A CN 103110925 A CN103110925 A CN 103110925A CN 201310080307 CN201310080307 CN 201310080307 CN 201310080307 A CN201310080307 A CN 201310080307A CN 103110925 A CN103110925 A CN 103110925A
Authority
CN
China
Prior art keywords
parts
herba
radix
fructus
medicament
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN 201310080307
Other languages
Chinese (zh)
Inventor
沈庆坡
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN 201310080307 priority Critical patent/CN103110925A/en
Publication of CN103110925A publication Critical patent/CN103110925A/en
Pending legal-status Critical Current

Links

Landscapes

  • Medicines Containing Plant Substances (AREA)

Abstract

The invention relates to a medicament for treating fracture. The medicament is prepared by the components in parts by weight as follows: 5-10 parts of radix scrophulariae, 10-20 parts of rhizoma zingiberis, 20-30 parts of dogwood, 10-20 parts of platycodon grandiflorum, 15-25 parts of radix angelicae, 5-15 parts of inula flower, 10-30 parts of the seed of cowherb, 1-15 parts of herba aristolochiae, 10-20 parts of radices sileris, 15-30 parts of ephedra, 20-30 parts of fructus terminaliae billericae, 1-20 parts of morinda officinalis, 1-20 parts of celandine, 10-25 parts of junci medulla, 10-30 parts of cocklebur fruit, 1-20 parts of emblic leafflower fruit, 15-20 parts of kamuning, 10-20 parts of kaladana, 15-20 parts of Japanese inula herb, 15-30 parts of herb of glabrous sarcandra, 10-20 parts of clinopodium polycephalum, 10-25 parts of sculellaria barbata, 5-15 parts of aleppo avens, 1-20 parts of gorgon fruit, 15-25 parts of cacumen biotae, 15-25 parts of potentilla discolor, 10-20 parts of calyx seu fructus physalis, 15-25 parts of the root bark of white mulberry, 20-30 parts of lindley eupatorium, 1-20 parts of radix dipsaci and 10-25 parts of Chinese azalea flower. All components of the medicament for treating fracture are natural materials, so that the medicament is better in safety, explicit in curative effect, and suitable for clinical large-scale popularization.

Description

A kind of medicament for the treatment of fracture
Technical field
The present invention relates to surgical field, relate in particular to a kind of medicament for the treatment of fracture.
Background technology
Fracture is the easy ill diseases of people, but adopts the analgesic treatment for the treatment of fracture at present more, and this can increase very large burden to the patient.And fracture has increasing trend.
Summary of the invention
The purpose of this invention is to provide a kind of medicament for the treatment of fracture.
in order to realize purpose of the present invention, the invention provides a kind of medicament for the treatment of fracture, it is to be made by the material of following weight proportioning: Radix Scrophulariae 5-10 part, Rhizoma Zingiberis 10-20 part, Fructus Corni 20-30 part, Radix Platycodonis 10-20 part, Radix Angelicae Dahuricae 15-25 part, Flos Inulae 5-15 part, Semen Vaccariae 10-30 part, Herba Aristolochiae 1-15 part, Radix Saposhnikoviae 10-20 part, Herba Ephedrae 15-30 part, Fructus Terminaliae Billericae 20-30 part, Radix Morindae Officinalis 1-20 part, Herba Chelidonii 1-20 part, Medulla Junci 10-25 part, Fructus Xanthii 10-30 part, Fructus Phyllanthi 1-20 part, Folium Et Cacumen Murrayae 15-20 part, Semen Pharbitidis 10-20 part, Herba Inulae 15-20 part, Herba Sarcandrae 15-30 part, Herba Clinopodii 10-20 part, Herba Scutellariae Barbatae 10-25 part, Radix seu Herba Gei aleppici 5-15 part, Semen Euryales 1-20 part, Cacumen Platycladi 15-25 part, Herba Potentillae Discoloris 15-25 part, Calyx Seu Fructus Physalis 10-20 part, Cortex Mori 15-25 part, Herba Eupatorii Lindleyani 20-30 part, Radix Dipsaci 1-20 part and Flos Rhododendri Mollis 10-25 part.
preferably, the medicament for the treatment of fracture of the present invention is to be made by the material of following weight proportioning: 7 parts of Radix Scrophulariaes, 13 parts of Rhizoma Zingiberiss, 22 parts of Fructus Corni, 15 parts of Radix Platycodoniss, 21 parts of the Radixs Angelicae Dahuricae, 13 parts of Flos Inulaes, 28 parts of Semen Vaccariae, 11 parts of Herba Aristolochiaes, 17 parts of Radix Saposhnikoviaes, 24 parts, Herba Ephedrae, 27 parts of Fructus Terminaliae Billericaees, 18 parts of Radix Morindae Officinaliss, 17 parts of Herba Chelidoniis, 23 parts of Medulla Juncies, 21 parts of Fructus Xanthii, 16 parts of Fructus Phyllanthis, 16 parts of Folium Et Cacumen Murrayae, 17 parts of Semen Pharbitidiss, 19 parts of Herba Inulae, 15 parts of Herba Sarcandraes, 14 parts of Herba Clinopodii, 21 parts of Herba Scutellariae Barbataes, 11 parts of Radix seu Herba Gei aleppici, 13 parts of Semen Euryaless, 23 parts of Cacumen Platycladis, 24 parts of Herba Potentillae Discoloris, 14 parts of Calyx Seu Fructus Physaliss, 25 parts of Cortex Mori, 26 parts of Herba Eupatorii Lindleyanis, 24 parts of 16 parts of Radix Dipsacis and Flos Rhododendri Mollis.
More preferably, described medicament can be tablet, dispersible tablet, capsule or decoction.
Whole compositions of the medicament for the treatment of fracture of the present invention are all natural materials, and safety is better, and curative effect is clear and definite, is suitable for large-scale promotion clinically.
The specific embodiment
Further illustrate the present invention below by embodiment.It should be understood that embodiments of the invention are for explanation the present invention rather than limitation of the present invention.Essence according to the present invention all belongs to the scope of protection of present invention to the simple modifications that the present invention carries out.Except as otherwise noted, otherwise the percent in the present invention is percetage by weight.
Embodiment decoction of the present invention
take Radix Scrophulariae 7 grams, Rhizoma Zingiberis 13 grams, Fructus Corni 22 grams, Radix Platycodonis 15 grams, the Radix Angelicae Dahuricae 21 grams, Flos Inulae 13 grams, Semen Vaccariae 28 grams, Herba Aristolochiae 11 grams, Radix Saposhnikoviae 17 grams, Herba Ephedrae 24 grams, Fructus Terminaliae Billericae 27 grams, Radix Morindae Officinalis 18 grams, Herba Chelidonii 17 grams, Medulla Junci 23 grams, Fructus Xanthii 21 grams, Fructus Phyllanthi 16 grams, Folium Et Cacumen Murrayae 16 grams, Semen Pharbitidis 17 grams, Herba Inulae 19 grams, Herba Sarcandrae 15 grams, Herba Clinopodii 14 grams, Herba Scutellariae Barbatae 21 grams, Radix seu Herba Gei aleppici 11 grams, Semen Euryales 13 grams, Cacumen Platycladi 23 grams, Herba Potentillae Discoloris 24 grams, Calyx Seu Fructus Physalis 14 grams, Cortex Mori 25 grams, Herba Eupatorii Lindleyani 26 grams, Radix Dipsaci 16 grams and Flos Rhododendri Mollis 24 grams, add 3000 milliliters of entry, in being housed, heated 5 hours under 90 ℃ by the flask of condensing tube, filter.Filtrate is concentrated into 500 milliliters, namely gets decoction of the present invention.
Experimental example
Choose 80 routine patients, male 40 examples, female's 40 examples; Age 17-68 year, average 38.5 years old; Fracture of femur 24 examples, fracture of tibia 18 examples, humeral fracture 16 examples, ulnar fracture 22 examples; Course of disease 6-24 month, average 11.2 months; Loose type 46 examples of nonunion type, atrophic type 34 examples.
Diagnostic criteria: fracture delayed union refers to that the fracture of a foot position and type fails healing within its average time (usually 3-6 month), as actively effectively not treating, may form bone does not connect.Clinical manifestation is for trouble limb rest pain, unstable, use is unable.During inspection, limbs have abnormal movement or pseudarthrosis.Can there be edema and tenderness in the part.It is clear that X-ray film shows as fracture line, and without callus formation, the bone does not connect X-ray film shows as the epiphysis sclerosis, the medullary cavity sealing, and two fracture ends form pestle mortar shape pseudarthrosis sometimes.Sometimes fracture end atrophy is loose, epiphysis gap increase.
Use the decoction of preparation in embodiment 1 to treat.Every day 3 times, each oral 70 milliliters, treating 30 days is a course for the treatment of.
Observe limbs pain, swelling, the movable and silly growing state of bone of patient treatment front and back.Clap respectively X-ray film in contrast before and after treatment.
Criterion of therapeutical effect
Produce effects: sx↓, limb activity can, X-ray film shows that fracture line is fuzzy, bone is silly to be formed.Effectively: sx↓, but limbs gentle activity, X-ray film show that fracture line is fuzzy or a small amount of callus formation are arranged.Invalid: symptom has no and alleviates, and limb activity is poor, and X-ray film shows that fracture line exists, and has no obvious callus formation.
After treatment 30 days, all patients sx↓, limb activity can, X-ray film shows that fracture line is fuzzy, bone is silly to be formed, and all meets the criterion of therapeutical effect of produce effects.

Claims (3)

1. medicament for the treatment of fracture, it is characterized in that, it is to be made by the material of following weight proportioning: Radix Scrophulariae 5-10 part, Rhizoma Zingiberis 10-20 part, Fructus Corni 20-30 part, Radix Platycodonis 10-20 part, Radix Angelicae Dahuricae 15-25 part, Flos Inulae 5-15 part, Semen Vaccariae 10-30 part, Herba Aristolochiae 1-15 part, Radix Saposhnikoviae 10-20 part, Herba Ephedrae 15-30 part, Fructus Terminaliae Billericae 20-30 part, Radix Morindae Officinalis 1-20 part, Herba Chelidonii 1-20 part, Medulla Junci 10-25 part, Fructus Xanthii 10-30 part, Fructus Phyllanthi 1-20 part, Folium Et Cacumen Murrayae 15-20 part, Semen Pharbitidis 10-20 part, Herba Inulae 15-20 part, Herba Sarcandrae 15-30 part, Herba Clinopodii 10-20 part, Herba Scutellariae Barbatae 10-25 part, Radix seu Herba Gei aleppici 5-15 part, Semen Euryales 1-20 part, Cacumen Platycladi 15-25 part, Herba Potentillae Discoloris 15-25 part, Calyx Seu Fructus Physalis 10-20 part, Cortex Mori 15-25 part, Herba Eupatorii Lindleyani 20-30 part, Radix Dipsaci 1-20 part and Flos Rhododendri Mollis 10-25 part.
2. the medicament for the treatment of according to claim 1 fracture, it is characterized in that, it is to be made by the material of following weight proportioning: 7 parts of Radix Scrophulariaes, 13 parts of Rhizoma Zingiberiss, 22 parts of Fructus Corni, 15 parts of Radix Platycodoniss, 21 parts of the Radixs Angelicae Dahuricae, 13 parts of Flos Inulaes, 28 parts of Semen Vaccariae, 11 parts of Herba Aristolochiaes, 17 parts of Radix Saposhnikoviaes, 24 parts, Herba Ephedrae, 27 parts of Fructus Terminaliae Billericaees, 18 parts of Radix Morindae Officinaliss, 17 parts of Herba Chelidoniis, 23 parts of Medulla Juncies, 21 parts of Fructus Xanthii, 16 parts of Fructus Phyllanthis, 16 parts of Folium Et Cacumen Murrayae, 17 parts of Semen Pharbitidiss, 19 parts of Herba Inulae, 15 parts of Herba Sarcandraes, 14 parts of Herba Clinopodii, 21 parts of Herba Scutellariae Barbataes, 11 parts of Radix seu Herba Gei aleppici, 13 parts of Semen Euryaless, 23 parts of Cacumen Platycladis, 24 parts of Herba Potentillae Discoloris, 14 parts of Calyx Seu Fructus Physaliss, 25 parts of Cortex Mori, 26 parts of Herba Eupatorii Lindleyanis, 24 parts of 16 parts of Radix Dipsacis and Flos Rhododendri Mollis.
3. the medicament for the treatment of fracture according to claim 1, is characterized in that, described medicament can be tablet, dispersible tablet, capsule or decoction.
CN 201310080307 2013-03-14 2013-03-14 Medicament for treating fracture Pending CN103110925A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN 201310080307 CN103110925A (en) 2013-03-14 2013-03-14 Medicament for treating fracture

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN 201310080307 CN103110925A (en) 2013-03-14 2013-03-14 Medicament for treating fracture

Publications (1)

Publication Number Publication Date
CN103110925A true CN103110925A (en) 2013-05-22

Family

ID=48409335

Family Applications (1)

Application Number Title Priority Date Filing Date
CN 201310080307 Pending CN103110925A (en) 2013-03-14 2013-03-14 Medicament for treating fracture

Country Status (1)

Country Link
CN (1) CN103110925A (en)

Similar Documents

Publication Publication Date Title
CN103157087A (en) Drug for treating femoral head necrosis
CN104083503A (en) Ointment for treating acute and chronic osteomyelitis and preparation method thereof
CN103142982A (en) Medicine for treating acute upper respiratory infection
CN102028835B (en) Chinese medicinal composition for treating fracture
CN103585457B (en) A kind of medicament for the treatment of fracture
CN103110925A (en) Medicament for treating fracture
CN106309774A (en) Nursing disinfectant for obstetrics and gynecology department and preparation method of nursing disinfectant
CN112168929A (en) Pharmaceutical composition and preparation method and application thereof
CN105535682A (en) External-application traditional Chinese medicine for treating traumatic synovitis of knee joint and preparation method
CN103157090A (en) Medicament for treating diarrhea
CN102240330B (en) Medicinal composition for strengthening bones
CN103316176B (en) Medicine for treating bone fracture
CN102552503B (en) Traditional Chinese medicine powder used for treating cervical erosion
CN103157085A (en) Drug for treating fracture
CN107617064A (en) A kind of Chinese medicine preparation for treating menopausal syndrome and preparation method thereof
CN103110923A (en) Medical method for treating scar
CN102068534B (en) Chinese medicinal composition for relaxing tendons and activating collaterals and preparation method thereof
CN105998515A (en) Plaster for orthopedics department
CN101120981A (en) Traditional Chinese medicine preparation for treating fracture and wound and pain and preparation process thereof
CN103142984B (en) Medicine for treating rheumatism
CN103110924A (en) Medicine for treating hemorrhoids
CN105012501A (en) External preparation for treating alopecia areata and preparing method of external preparation
CN104116859A (en) Traditional Chinese medicinal decoction for treating bone fracture
CN103142971A (en) Medicine for treating bone diseases
CN103157081A (en) Medicament for relaxing tendons and activating collaterals

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C12 Rejection of a patent application after its publication
RJ01 Rejection of invention patent application after publication

Application publication date: 20130522